Literature DB >> 11078562

Standard growth curves for Japanese patients with Prader-Willi syndrome.

T Nagai1, N Matsuo, Y Kayanuma, H Tonoki, Y Fukushima, H Ohashi, T Murai, T Hasegawa, Y Kuroki, N Niikawa.   

Abstract

We constructed the standard growth (length/height and weight) curves for Japanese individuals with Prader-Willi syndrome (PWS). Crude height and weight data were collected from 153 males and 99 females with the syndrome, and the collected data were arranged by a mathematical method to construct the curves. Height growth patterns were quite different between PWS and normal children. Mean height of individuals with the syndrome by puberty is -2 SD for normal children, and it drops off far below -2 SD value after puberty. Final mean height is 141.2 +/- 4.8 cm for females (n = 13) and 147.7 +/- 7.7 cm for males (n = 17), showing 15.8 and 21.9 cm below the average height for normal Japanese girls and boys, respectively. Thus, the degree of shortness is more pronounced in male than in female patients. There was no difference in height between those with chromosome 15q deletion and those without. Mean weight at birth of girls (n = 88) and boys (n = 131) were 2.70 +/- 0.45 Kg and 2.62 +/- 0.47 Kg, respectively. These values were smaller than those for normal neonates (P < 0.05, t-test). The weight of PWS children was under the mean value for normal infants by age 2 years, but gradually increase above the mean values for normal children around ages 2-4 years. Overweight in both males and females becomes obvious during prepuberty. Growth patterns are not different between Japanese and Caucasian children with the syndrome. Short stature is more prominent in boys of both ethnic groups, whereas the degree of overweight appears much more severe in Caucasians. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11078562     DOI: 10.1002/1096-8628(20001113)95:2<130::aid-ajmg7>3.0.co;2-r

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

Review 1.  Growth hormone therapy in the Prader-Willi syndrome.

Authors:  W F Paterson; M D C Donaldson
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

2.  Clinical management of behavioral characteristics of Prader-Willi syndrome.

Authors:  Alan Y Ho; Anastasia Dimitropoulos
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

3.  Growth references for Japanese individuals with Noonan syndrome.

Authors:  Tsuyoshi Isojima; Satoru Sakazume; Tomonobu Hasegawa; Tsutomu Ogata; Toshio Nakanishi; Toshiro Nagai; Susumu Yokoya
Journal:  Pediatr Res       Date:  2015-12-09       Impact factor: 3.953

Review 4.  Development of disease-specific growth charts in Turner syndrome and Noonan syndrome.

Authors:  Tsuyoshi Isojima; Susumu Yokoya
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-12-31

5.  Establishment of a longitudinal growth chart corresponding to pubertal timing.

Authors:  Keisuke Yoshii; Toshiaki Tanaka
Journal:  Clin Pediatr Endocrinol       Date:  2018-10-30

6.  Successful peritoneal dialysis for the end-stage kidney disease associated with Prader-Willi syndrome: a case report.

Authors:  Emi Anno; Keiichiro Hori; Ainori Hoshimoto; Makiko Harano; Sou Hagiwara; Kaori Oishi; Yoshinari Yokoyama; Yusuke Tsukamoto; Minoru Kubota
Journal:  CEN Case Rep       Date:  2019-04-08

7.  Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation.

Authors:  Boris V Skryabin; Leonid V Gubar; Birte Seeger; Jana Pfeiffer; Sergej Handel; Thomas Robeck; Elena Karpova; Timofey S Rozhdestvensky; Jürgen Brosius
Journal:  PLoS Genet       Date:  2007-12-28       Impact factor: 5.917

8.  Growth charts for Thai children with Prader-Willi syndrome aged 0-18 years.

Authors:  Nantiya Mongkollarp; Thipwimol Tim-Aroon; Chusak Okascharoen; Khunton Wichajarn; Jeeraparn Phosuwattanakul; Nalinee Chongviriyaphan; Duangrurdee Wattanasirichaigoon
Journal:  Orphanet J Rare Dis       Date:  2020-05-06       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.